Imunon Statistics

Share Statistics

Imunon has 2.52M shares outstanding. The number of shares has increased by 1.51% in one year.

Shares Outstanding	2.52M
Shares Change (YoY)	1.51%
Shares Change (QoQ)	-0.02%
Owned by Institutions (%)	2.35%
Shares Floating	2.45M
Failed to Deliver (FTD) Shares	8,953
FTD / Avg. Volume	1.81%

Short Selling Information

The latest short interest is 237.43K, so 9.73% of the outstanding shares have been sold short.

Short Interest	237.43K
Short % of Shares Out	9.73%
Short % of Float	9.8%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -0.68 and the forward PE ratio is -2.47. Imunon's PEG ratio is 0.03.

PE Ratio	-0.68
Forward PE	-2.47
PS Ratio	0
Forward PS	4
PB Ratio	2.96
P/FCF Ratio	-0.67
PEG Ratio	0.03

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Imunon.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.27.

Current Ratio	1.67
Quick Ratio	1.67
Debt / Equity	0.27
Debt / EBITDA	-0.06
Debt / FCF	-0.06
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-744.81K
Employee Count	25
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by -64.14% in the last 52 weeks. The beta is 2.16, so Imunon's price volatility has been higher than the market average.

Beta	2.16
52-Week Price Change	-64.14%
50-Day Moving Average	9.09
200-Day Moving Average	12.91
Relative Strength Index (RSI)	38.38
Average Volume (20 Days)	493,827

Income Statement

Revenue	n/a
Gross Profit	-718.12K
Operating Income	-19.13M
Net Income	-18.62M
EBITDA	-17.98M
EBIT	-18.7M
Earnings Per Share (EPS)	-21.1

Full Income Statement

Balance Sheet

The company has 5.87M in cash and 1.14M in debt, giving a net cash position of 4.73M.

Cash & Cash Equivalents	5.87M
Total Debt	1.14M
Net Cash	4.73M
Retained Earnings	-406.8M
Total Assets	8.79M
Working Capital	1.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.85M and capital expenditures -29.54K, giving a free cash flow of -18.88M.

Operating Cash Flow	-18.85M
Capital Expenditures	-29.54K
Free Cash Flow	-18.88M
FCF Per Share	-21.4

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IMNN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for IMNN is $280.44, which is 4394.2% higher than the current price. The consensus rating is "Buy".

Price Target	$280.44
Price Target Difference	4394.2%
Analyst Consensus	Buy
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Jul 25, 2025. It was a backward split with a ratio of 1:15.

Last Split Date	Jul 25, 2025
Split Type	backward
Split Ratio	1:15

Scores

Altman Z-Score	-69.93
Piotroski F-Score	2

Imunon Inc. (IMNN)